Altmetric
Characterising illness stages and recovery trajectories of eating disorders in young people via remote measurement technology (STORY): a multi-centre prospective cohort study protocol
File | Description | Size | Format | |
---|---|---|---|---|
s12888-024-05841-w.pdf | Published version | 1.33 MB | Adobe PDF | View/Open |
Title: | Characterising illness stages and recovery trajectories of eating disorders in young people via remote measurement technology (STORY): a multi-centre prospective cohort study protocol |
Authors: | Kuehne, C Phillips, MD Moody, S Bryson, C Campbell, IC Conde, P Cummins, N Desrivières, S Dineley, J Dobson, R Douglas, D Folarin, A Gallop, L Hemmings, A İnce, B Mason, L Rashid, Z Bromell, A Sims, C Allen, K Bailie, C Bains, P Basher, M Battisti, F Baudinet, J Bristow, K Dawson, N Dodd, L Frater, V Freudenthal, R Gripton, B Kan, C Khor, JWT Kotze, N Laverack, S Martin, L Maxwell, S McDonald, S McKnight, D McKay, R Merrin, J Nash, M Nicholls, D Palmer, S Pearce, S Roberts, C Serpell, L Severs, E Simic, M Staton, A Westaway, S Sharpe, H Schmidt, U EDIFY consortium Bartel, H French, T Kelly, J Micali, N Raman, S Treasure, J Malik, U Rabelo-da-Ponte, D Stephens, F Opitz, T Trompeter, N Wilkins, J Parnell, T Abbas, R Bromell, A Davis, G Eadie, C Gracie, L Heslop, B McKenzie, K Odubanjo, E Sims, C Street, T Tavares-Semedo, A Wilkinson, E Zocek, L |
Item Type: | Journal Article |
Abstract: | BACKGROUND: Eating disorders (EDs) are serious, often chronic, conditions associated with pronounced morbidity, mortality, and dysfunction increasingly affecting young people worldwide. Illness progression, stages and recovery trajectories of EDs are still poorly characterised. The STORY study dynamically and longitudinally assesses young people with different EDs (restricting; bingeing/bulimic presentations) and illness durations (earlier; later stages) compared to healthy controls. Remote measurement technology (RMT) with active and passive sensing is used to advance understanding of the heterogeneity of earlier and more progressed clinical presentations and predictors of recovery or relapse. METHODS: STORY follows 720 young people aged 16-25 with EDs and 120 healthy controls for 12 months. Online self-report questionnaires regularly assess ED symptoms, psychiatric comorbidities, quality of life, and socioeconomic environment. Additional ongoing monitoring using multi-parametric RMT via smartphones and wearable smart rings ('Ōura ring') unobtrusively measures individuals' daily behaviour and physiology (e.g., Bluetooth connections, sleep, autonomic arousal). A subgroup of participants completes additional in-person cognitive and neuroimaging assessments at study-baseline and after 12 months. DISCUSSION: By leveraging these large-scale longitudinal data from participants across ED diagnoses and illness durations, the STORY study seeks to elucidate potential biopsychosocial predictors of outcome, their interplay with developmental and socioemotional changes, and barriers and facilitators of recovery. STORY holds the promise of providing actionable findings that can be translated into clinical practice by informing the development of both early intervention and personalised treatment that is tailored to illness stage and individual circumstances, ultimately disrupting the long-term burden of EDs on individuals and their families. |
Issue Date: | 30-May-2024 |
Date of Acceptance: | 13-May-2024 |
URI: | http://hdl.handle.net/10044/1/112512 |
DOI: | 10.1186/s12888-024-05841-w |
ISSN: | 1471-244X |
Publisher: | Springer Nature |
Journal / Book Title: | BMC Psychiatry |
Volume: | 24 |
Copyright Statement: | © The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
Publication Status: | Published |
Conference Place: | England |
Article Number: | 409 |
Online Publication Date: | 2024-05-30 |
Appears in Collections: | Department of Brain Sciences |
This item is licensed under a Creative Commons License